StockData
Boston Scientific Corp logo

Boston Scientific Corp

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3055% below fair value
$41.98−1.01 (-2.35%)

Close on Nov 20, 2026Market cap $60.84BP/E 17.0Yield –

Boston Scientific Restructuring Charges Incurred by Quarter

Restructuring Charges Incurred ($M) ($M)

Boston Scientific Restructuring Charges Incurred: $63M in Q3 2026, down 887.5% from a year earlier.

Latest, Q3 2026
63
Period ended Sep 30, 2026
Change on a year earlier
-887.5%
-8 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
38
Documents cited below

Where the Q3 2026 figure comes from

Source: Form 10-Q — FY2026Q3 (filed 2026-11-02) ↗

Reported in Form 10-K/10-Q Restructuring Footnote.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRestructuring Charges Incurred ($M) ($M)Year on yearSource
Q3 2026Sep 30, 202663-887.5%Form 10-Q — FY2026Q3 (filed 2026-11-02) ↗
Q2 2026Jun 30, 20268-90.4%Form 10-Q — FY2026Q2 (filed 2026-08-03) ↗
Q1 2026Mar 31, 20263-70.0%Form 10-Q — FY2026Q1 (filed 2026-05-01) ↗
Q4 2025Dec 31, 202516+300.0%Form EX21 — FY2025 (filed 2026-02-17) ↗
Q3 2025Sep 30, 2025-8-200.0%Form 10-Q — FY2026Q3 (filed 2026-11-02) ↗
Q2 2025Jun 30, 202583+8,200.0%Form 10-Q — FY2026Q2 (filed 2026-08-03) ↗
Q1 2025Mar 31, 202510+233.3%Form 10-Q — FY2026Q1 (filed 2026-05-01) ↗
Q4 2024Dec 31, 20244-77.8%Form EX21 — FY2025 (filed 2026-02-17) ↗
Q3 2024Sep 30, 20248-46.7%Form 10-Q — FY2025Q3 (filed 2025-11-03) ↗
Q2 2024Jun 30, 20241-93.7%Form 10-Q — FY2025Q2 (filed 2025-08-01) ↗
Q1 2024Mar 31, 20243-85.0%Form 10-Q — FY2025Q1 (filed 2025-05-01) ↗
Q4 2023Dec 31, 202318+200.0%Form EX21 — FY2025 (filed 2026-02-17) ↗
Q3 2023Sep 30, 202315+275.0%Form 10-Q — FY2024Q3 (filed 2024-11-01) ↗
Q2 2023Jun 30, 202316+45.5%Form 10-Q — FY2024Q2 (filed 2024-08-01) ↗
Q1 2023Mar 31, 202320+400.0%Form 10-Q — FY2024Q1 (filed 2024-05-01) ↗
Q4 2022Dec 31, 20226-72.7%Form EX21 — FY2024 (filed 2025-02-18) ↗

Cite this data

StockData. (2026). Boston Scientific Restructuring Charges Incurred ($M), quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/fn-restruct-chg

See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?